New data from parts 1 and 2 of the ongoing ARIEL2 phase II trial was presented in oral sessions at the 2017 Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer in National Harbor, MD. New data from these presentations include...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nwhpAr
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: October 2017 Source: International Journal of Biological Macromolecules, Volume 103 Author(s): Mingan Yu, Duqiang Liu, ...
-
Abstract Endurance exercise generates CO 2 via aerobic metabolism; however, its role remains unclear. Exogenous CO 2 by transcutaneous d...
-
FS Teni, AS Surur, A Hailemariam, A Aye, G Mitiku, AE Gurmu, B Tessema Annals of Medical and Health Sciences Research 2015 5(6):454-460 ...
-
Abstract Background Studies exploring the association between physical activity, screen time and sleep and pain usually focus on a limit...
-
RT @caonline : The role of extranodal extension in staging head and neck cancers: http://ift.tt/2qV1As1 #hncsm https://t.co/MxlLX4Olo6 f...
-
One third of adult patients with orthognathic surgery of a prognathic or retrognathic mandible show relapse. The sagittal split osteotomy of...
-
Abstract This paper analyzes the most and least used upper limb aquatic equipment for hydrotherapy/hydro kinesiology specialists in the tr...
-
Abstract Wheat germ has an important enzymatic activity, being lipases the enzymes which cause the highest impact in the reduction of shelf...
-
Medicine by Alexandros G. Sfakianakis BioMed Research International BioMed Research InternationalTanshinone IIA Alleviates CCL2-Induced Le...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου